Numerous court decisions over the past decade – such as Amgen Inc. v. Sanofi from the US Supreme Court and Juno Therapeutics, Inc. et al. v.

Achievement strengthens iBio’s partnered cardiometabolic and obesity program while showcasing its proprietary AI-driven drug ...

For modern biotherapeutics, cell line development workflows must include more than just automated liquid handling.

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

NanoImaging Services ("NIS"), the leading provider of cryo-electron microscopy ("cryo-EM") services for drug discovery and ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today ...

HB-0036 is under clinical development by Huabo Biopharm (Shanghai) and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs for Melanoma have a 27% phase transition success rate ...

NIH Researchers Discover Novel Class of Anti-Malaria Antibodies - New Antibodies Could Lead to Generation of Interventions ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.